CD4 and neoplasm: The results revealed a significant reduction in various anti-tumor immune cells, including CD4+ central memory T cells, dendritic cells, mast cells, natural killer T cells, and monocytes, in the high-risk group, whereas T helper 2 (Th2) cells were increased.